No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct ‐acting antivirals for hepatitis C in a large real‐world cohort

ConclusionsHBV reactivation was not observed in HBsAg‐negative/HBcAb‐positive patients but common in HBsAg‐positive/HBcAb‐positive patients treated with different combinations of DAAs for HCV.

Source: Alimentary Pharmacology and Therapeutics - June 19, 2017 Category: Drugs & Pharmacology Authors: V. T. M ücke, M. M. Mücke, K.‐H. Peiffer, N. Weiler, T. M. Welzel, C. Sarrazin, S. Zeuzem, A. Berger, J. Vermehren Tags: ORIGINAL ARTICLE Source Type: research